Nexin-1 inhibits the activity of human brain trypsin

Neuroscience

Volumn 160, Issue 1, 2009, Pages 97-102

  Koistinen, H ^a   Koistinen, R ^a,b   Zhang, W M ^a   Valmu, L ^a   Stenman, U H ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

PAR; serine proteases; serpin

Indexed keywords

PROTEASE NEXIN I; TRYPSIN; TRYPSIN 4; UNCLASSIFIED DRUG;

ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME STABILITY; HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION;

AMYLOID BETA-PROTEIN PRECURSOR; BLOTTING, WESTERN; BRAIN; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ESCHERICHIA COLI; HUMANS; ISOENZYMES; KINETICS; RECEPTORS, CELL SURFACE; RECOMBINANT PROTEINS; TRYPSIN; TRYPSIN INHIBITORS;

EID: 63649106408     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2009.02.042     Document Type: Article

References (38)

1. Baker J.B., Low D.A., Simmer R.L., and Cunningham D.D. Protease-nexin: a cellular component that links thrombin and plasminogen activator and mediates their binding to cells. Cell 21 (1980) 37-45
2. Chase T.J., and Shaw E. Titration of trypsin, plasmin, and thrombin with p-nitrophenyl p′-guanidinobenzoate HCl. Methods Enzymol 19 (1970) 20-27
3. Choi B.H., Suzuki M., Kim T., Wagner S.L., and Cunningham D.D. Protease nexin-1 localization in the human brain suggests a protective role against extravasated serine proteases. Am J Pathol 137 (1990) 741-747
4. Cottrell G.S., Amadesi S., Grady E.F., and Bunnett N.W. Trypsin IV, a novel agonist of protease-activated receptors 2 and 4. J Biol Chem 279 (2004) 13532-13539
5. Cunningham D.D., and Gurwitz D. Proteolytic regulation of neurite outgrowth from neuroblastoma cells by thrombin and protease nexin-1. J Cell Biochem 39 (1989) 55-64
6. Djie M.Z., Stone S.R., and Le Bonniec B.F. Intrinsic specificity of the reactive site loop of alpha1-antitrypsin, alpha1-antichymotrypsin, antithrombin III, and protease nexin I. J Biol Chem 272 (1997) 16268-16273
7. Gettins P.G. Serpin structure, mechanism, and function. Chem Rev 102 (2002) 4751-4804
8. Grishina Z., Ostrowska E., Halangk W., Sahin-Toth M., and Reiser G. Activity of recombinant trypsin isoforms on human proteinase-activated receptors (PAR): mesotrypsin cannot activate epithelial PAR-1, -2, but weakly activates brain PAR-1. Br J Pharmacol 146 (2005) 990-999
9. Guy O., Lombardo D., Bartelt D.C., Amic J., and Figarella C. Two human trypsinogens. Purification, molecular properties, and N-terminal sequences. Biochemistry 17 (1978) 1669-1675
10. Haverback B.J., Dyce B., Bundy H., and Edmondson H.A. Trypsin, trypsinogen and trypsin inhibitor in human pancreatic juice. Am J Med 29 (1960) 421-433
11. Itkonen O., Koivunen E., Hurme M., Alfthan H., Schroder T., and Stenman U.H. Time-resolved immunofluorometric assays for trypsinogen-1 and 2 in serum reveal preferential elevation of trypsinogen-2 in pancreatitis. J Lab Clin Med 115 (1990) 712-718
12. Knecht W., Cottrell G.S., Amadesi S., Mohlin J., Skaregarde A., Gedda K., Peterson A., Chapman K., Hollenberg M.D., Vergnolle N., and Bunnett N.W. Trypsin IV or mesotrypsin and p23 cleave protease-activated receptors 1 and 2 to induce inflammation and hyperalgesia. J Biol Chem 282 (2007) 26089-26100
13. Kukor Z., Toth M., and Sahin-Toth M. Human anionic trypsinogen: properties of autocatalytic activation and degradation and implications in pancreatic diseases. Eur J Biochem 270 (2003) 2047-2058
14. Luo W., Wang Y., and Reiser G. Protease-activated receptors in the brain: receptor expression, activation, and functions in neurodegeneration and neuroprotection. Brain Res Rev 56 (2007) 331-345
15. Mansuy I.M., van der Putten H., Schmid P., Meins M., Botteri F.M., and Monard D. Variable and multiple expression of protease nexin-1 during mouse organogenesis and nervous system development. Development 119 (1993) 1119-1134
16. Medveczky P., Antal J., Patthy A., Kekesi K., Juhasz G., Szilagyi L., and Graf L. Myelin basic protein, an autoantigen in multiple sclerosis, is selectively processed by human trypsin 4. FEBS Lett 580 (2006) 545-552
17. Meier R., Spreyer P., Ortmann R., Harel A., and Monard D. Induction of glia-derived nexin after lesion of a peripheral nerve. Nature 342 (1989) 548-550
18. Minn A., Schubert M., Neiss W.F., and Muller-Hill B. Enhanced GFAP expression in astrocytes of transgenic mice expressing the human brain-specific trypsinogen IV. Glia 22 (1998) 338-347
19. Nemeth A.L., Medveczky P., Toth J., Siklodi E., Schlett K., Patthy A., Palkovits M., Ovadi J., Tokesi N., Nemeth P., Szilagyi L., and Graf L. Unconventional translation initiation of human trypsinogen 4 at a CUG codon with an N-terminal leucine. A possible means to regulate gene expression. FEBS J 274 (2007) 1610-1620
20. Nitsch C., Scotti A.L., Monard D., Heim C., and Sontag K.H. The glia-derived protease nexin 1 persists for over 1 year in rat brain areas selectively lesioned by transient global ischaemia. Eur J Neurosci 5 (1993) 292-297
21. Nyaruhucha C.N., Kito M., and Fukuoka S.I. Identification and expression of the cDNA-encoding human mesotrypsin(Ogen), an isoform of trypsin with inhibitor resistance. J Biol Chem 272 (1997) 10573-10578
22. Osman S., Turpeinen U., Itkonen O., and Stenman U.H. Optimization of a time-resolved immunofluorometric assay for tumor-associated trypsin inhibitor (TATI) using the streptavidin-biotin system. J Immunol Methods 161 (1993) 97-106
23. Paju A., and Stenman U.H. Biochemistry and clinical role of trypsinogens and pancreatic secretory trypsin inhibitor. Crit Rev Clin Lab Sci 43 (2006) 103-142
24. Richard B., Pichon S., Arocas V., Venisse L., Berrou E., Bryckaert M., Jandrot-Perrus M., and Bouton M.C. The serpin protease nexin-1 regulates vascular smooth muscle cell adhesion, spreading, migration and response to thrombin. J Thromb Haemost 4 (2006) 322-328
25. Riek-Burchardt M., Striggow F., Henrich-Noack P., Reiser G., and Reymann K.G. Increase of prothrombin-mRNA after global cerebral ischemia in rats, with constant expression of protease nexin-1 and protease-activated receptors. Neurosci Lett 329 (2002) 181-184
26. Sahin-Toth M. Human cationic trypsinogen. Role of Asn-21 in zymogen activation and implications in hereditary pancreatitis. J Biol Chem 275 (2000) 22750-22755
27. Sahin-Toth M. Human mesotrypsin defies natural trypsin inhibitors: from passive resistance to active destruction. Protein Pept Lett 12 (2005) 457-464
28. Schechter N.M., and Plotnick M.I. Measurement of the kinetic parameters mediating protease-serpin inhibition. Methods 32 (2004) 159-168
29. Scott R.W., Bergman B.L., Bajpai A., Hersh R.T., Rodriguez H., Jones B.N., Barreda C., Watts S., and Baker J.B. Protease nexin. Properties and a modified purification procedure. J Biol Chem 260 (1985) 7029-7034
30. Stone S.R., and Hermans J.M. Inhibitory mechanism of serpins. Interaction of thrombin with antithrombin and protease nexin 1. Biochemistry 34 (1995) 5164-5172
31. Stone S.R., Nick H., Hofsteenge J., and Monard D. Glial-derived neurite-promoting factor is a slow-binding inhibitor of trypsin, thrombin, and urokinase. Arch Biochem Biophys 252 (1987) 237-244
32. Szepessy E., and Sahin-Toth M. Human mesotrypsin exhibits restricted S1′ subsite specificity with a strong preference for small polar side chains. FEBS J 273 (2006) 2942-2954
33. Szmola R., Kukor Z., and Sahin-Toth M. Human mesotrypsin is a unique digestive protease specialized for the degradation of trypsin inhibitors. J Biol Chem 278 (2003) 48580-48589
34. Toth J., Siklodi E., Medveczky P., Gallatz K., Nemeth P., Szilagyi L., Graf L., and Palkovits M. Regional distribution of human trypsinogen 4 in human brain at mRNA and protein level. Neurochem Res 32 (2007) 1423-1433
35. Wang Y., Luo W., and Reiser G. Trypsin and trypsin-like proteases in the brain: proteolysis and cellular functions. Cell Mol Life Sci 65 (2008) 237-252
36. Wang Y., Luo W., Wartmann T., Halangk W., Sahin-Toth M., and Reiser G. Mesotrypsin, a brain trypsin, activates selectively proteinase-activated receptor-1, but not proteinase-activated receptor-2, in rat astrocytes. J Neurochem 99 (2006) 759-769
37. Wiegand U., Corbach S., Minn A., Kang J., and Muller-Hill B. Cloning of the cDNA encoding human brain trypsinogen and characterization of its product. Gene 136 (1993) 167-175
38. Yan J.X., Wait R., Berkelman T., Harry R.A., Westbrook J.A., Wheeler C.H., and Dunn M.J. A modified silver staining protocol for visualization of proteins compatible with matrix-assisted laser desorption/ionization and electrospray ionization-mass spectrometry. Electrophoresis 21 (2000) 3666-3672